These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1078744)

  • 41. T lymphoreceptopathy in systemic lupus erythematosus.
    Arimori S; Koriyama K; Hiramatsu K; Shimizu Y; Matsumura Y
    Tokai J Exp Clin Med; 1980 Oct; 5(4):385-98. PubMed ID: 6972633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Systemic lupus erythematosus. Clinical, biological and immunological studies. (Report on 30 cases). II].
    Nouspikel P
    Praxis; 1968 Jun; 57(24):875-90. PubMed ID: 4888332
    [No Abstract]   [Full Text] [Related]  

  • 43. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
    Huber C; Pfister R; Stingl G
    Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of T-lymphocyte and killer-cell defects in the pathogenesis of systemic lupus erythematodes].
    Wollina U
    Dermatol Monatsschr; 1983; 169(12):749-61. PubMed ID: 6230266
    [No Abstract]   [Full Text] [Related]  

  • 45. Idiotypes in systemic lupus erythematosus. Clues for understanding etiology and pathogenicity.
    Shefner R; Manheimer-Lory A; Davidson A; Paul E; Aranow C; Katz J; Diamond B
    Chem Immunol; 1990; 48():82-108. PubMed ID: 2294929
    [No Abstract]   [Full Text] [Related]  

  • 46. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
    Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging concepts in the molecular pathogenesis of systemic lupus erythematosus.
    Nambiar MP; Juang YT; Tsokos GC
    Arch Immunol Ther Exp (Warsz); 2002; 50(1):35-45. PubMed ID: 11916307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An update on pathogenesis of systemic lupus erythematosus.
    Ahmadpoor P; Dalili N; Rostami M
    Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on the lysis of lymphocytes of patients with systemic lupus erythematosus--with relation to lymphocyte subpopulation (author's transl)].
    Tanaka Z
    Ryumachi; 1977 Jul; 17(4):388-95. PubMed ID: 302991
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytodestructive mechanisms provoked by lymphocytes.
    Podleski WK
    Am J Med; 1976 Jul; 61(1):1-8. PubMed ID: 779467
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunity system].
    Resch K
    Internist (Berl); 1977 May; 18(5):233-47. PubMed ID: 326714
    [No Abstract]   [Full Text] [Related]  

  • 52. Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.
    Abdou NI; Sagawa A; Pascual E; Hebert J; Sadeghee S
    Clin Immunol Immunopathol; 1976 Sep; 6(2):192-9. PubMed ID: 1085685
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies.
    Butler WT; Sharp JT; Rossen RD; Lidsky MD; Mittal KK; Gard DA
    Arthritis Rheum; 1972; 15(3):251-8. PubMed ID: 4537448
    [No Abstract]   [Full Text] [Related]  

  • 54. Differential specificity of lymphocytotoxins from patients with systemic lupus erythematosus and inflammatory bowel disease.
    Korsmeyer SJ; Strickland RG; Ammann AJ; Waldmann TA; Williams RC
    Clin Immunol Immunopathol; 1976 Jan; 5(1):67-73. PubMed ID: 1083322
    [No Abstract]   [Full Text] [Related]  

  • 55. Membrane markers of lymphocytes in lymphomas, melanoma and lupus erythematosus.
    Edelson RL
    Int J Dermatol; 1976 Oct; 15(8):577-86. PubMed ID: 786913
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic, environmental, and cellular factors in the pathogenesis of systemic lupus erythematosus.
    Steinberg AD; Raveche ES; Laskin CA; Miller ML; Steinberg RT
    Arthritis Rheum; 1982 Jul; 25(7):734-43. PubMed ID: 6179521
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial: Killer T cells.
    Henney CS
    N Engl J Med; 1974 Dec; 291(25):1357-8. PubMed ID: 4372532
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-lymphocyte antibodies in the pathogenesis of SLE.
    Searles RP; Williams RC
    Clin Exp Rheumatol; 1986; 4(2):175-82. PubMed ID: 3524939
    [No Abstract]   [Full Text] [Related]  

  • 59. The virus hypothesis in systemic lupus erythematosus.
    Phillips PE
    Ann Intern Med; 1975 Nov; 83(5):709-15. PubMed ID: 938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial: A virus in S.L.E.?
    Lancet; 1974 Nov; 2(7892):1302. PubMed ID: 4139535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.